Jaguar Health (JAGX) Other Non-Current Assets (2015 - 2026)
Jaguar Health (JAGX) posted quarterly Other Non-Current Assets of $2.8 million for Q1 2026, up 106.83% year-over-year from $1.3 million in Q1 2025, and up 463.97% quarter-over-quarter from $494000.0 in Q4 2025.
Jaguar Health (JAGX) Other Non-Current Assets (2015 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Other Non-Current Assets for 12 consecutive years, with $2.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Assets rose 106.83% year-over-year to $2.8 million; the TTM figure through Mar 2026 stood at $2.8 million (up 106.83% YoY), while the FY2025 annual figure was $494000.0, down 63.35% from the prior year.
- Other Non-Current Assets climbed to $2.8 million in Q1 2026 per JAGX's latest filing, from $494000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $2.8 million in Q1 2026 and bottomed at $275000.0 in Q1 2024.
- Historically, Other Non-Current Assets has averaged $1.1 million across 5 years, with a median of $1.0 million in 2023.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets surged 2247.37% — and 2024, when it plunged 72.83%.
- Jaguar Health's Other Non-Current Assets stood at $995000.0 in 2022, then climbed by 1.71% to $1.0 million in 2023, then soared by 33.2% to $1.3 million in 2024, then sank by 63.35% to $494000.0 in 2025, then jumped by 463.97% to $2.8 million in 2026.
- Business Quant data shows JAGX's Other Non-Current Assets at $2.8 million in Q1 2026, $494000.0 in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 618.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 109.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 65.13 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 202.31 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 104.44 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 62.96 Mn |
| 10 | Jaguar Health | 447,549.24 | -9.62 Mn | 19.11 Mn | 2.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.79 Mn |
| Dec 31, 2025 | 494,000.00 |
| Sep 30, 2025 | 1.24 Mn |
| Jun 30, 2025 | 1.24 Mn |
| Mar 31, 2025 | 1.35 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 276,000.00 |
| Mar 31, 2024 | 275,000.00 |
| Dec 31, 2023 | 1.01 Mn |
| Sep 30, 2023 | 1.01 Mn |
| Jun 30, 2023 | 1.01 Mn |
| Mar 31, 2023 | 1.01 Mn |
| Dec 31, 2022 | 995,000.00 |
| Sep 30, 2022 | 1.84 Mn |
| Jun 30, 2022 | 1.75 Mn |
| Mar 31, 2022 | 446,000.00 |
| Dec 31, 2021 | 446,000.00 |
| Mar 31, 2021 | 19,000.00 |
| Dec 31, 2020 | 37,000.00 |